Holen Sie sich die Stockscreener-App
1.37
6.80%
-0.10
Relmada Therapeutics Inc Aktie (RLMD) Neueste Nachrichten
Exclusive: Relmada CEO says his recent buy reflects ’significant undervaluation’ - Investing.com
Leading vs lagging indicators on Relmada Therapeutics Inc. performanceWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
Relmada Therapeutics Inc. Price Targets Raised After ReboundGap Up & Weekly High Momentum Picks - beatles.ru
Analyzing recovery setups for Relmada Therapeutics Inc. investorsJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Will Relmada Therapeutics Inc. continue its uptrendShort Setup & Smart Money Movement Alerts - Newser
Is Relmada Therapeutics Inc. trending in predictive chart modelsJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Published on: 2025-09-03 14:56:26 - khodrobank.com
Published on: 2025-09-03 04:51:26 - Newser
Real time scanner hits for Relmada Therapeutics Inc. explained2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Analyzing drawdowns of Relmada Therapeutics Inc. with statistical toolsMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Relmada Therapeutics Inc.Jobs Report & Community Consensus Trade Signals - Newser
Can technical indicators confirm Relmada Therapeutics Inc.’s reversalMarket Risk Report & Safe Entry Momentum Tips - Newser
Is now a turning point for Relmada Therapeutics Inc.July 2025 Movers & High Accuracy Swing Entry Alerts - Newser
How to integrate Relmada Therapeutics Inc. into portfolio analysis tools2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Using R and stats models for Relmada Therapeutics Inc. forecasting2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
Can machine learning forecast Relmada Therapeutics Inc. recoveryJuly 2025 Opening Moves & Safe Entry Zone Tips - Newser
Can Relmada Therapeutics Inc. be recession proofQuarterly Portfolio Review & Capital Efficiency Focused Ideas - khodrobank.com
What is Relmada Therapeutics Inc. s revenue forecastJuly 2025 Pullbacks & Short-Term High Return Ideas - khodrobank.com
What is Relmada Therapeutics Inc. s P E ratio telling us2025 Buyback Activity & Risk Managed Trade Strategies - khodrobank.com
Can momentum traders help lift Relmada Therapeutics Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Relmada Therapeutics executive purchases 55,000 shares on open market - Investing.com
Relmada Therapeutics CMO Purchases 55,000 Shares - TipRanks
What the charts say about Relmada Therapeutics Inc. today2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
What’s next for Relmada Therapeutics Inc. stock priceMarket Performance Report & Real-Time Buy Zone Alerts - Newser
Relmada Therapeutics (RLMD): Is the 91% Response Rate in Bladder Cancer a Catalyst for a Phase 3-Driven Bull Run? - AInvest
Will Relmada Therapeutics Inc. see short term momentumOptions Play & Low Volatility Stock Recommendations - Newser
Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study - Yahoo Finance
Is Relmada Therapeutics Inc.’s growth already priced inQuarterly Growth Report & Fast Moving Trade Plans - kpenews.com
Should value investors consider Relmada Therapeutics Inc.2025 Year in Review & Safe Entry Momentum Stock Tips - khodrobank.com
Is Relmada Therapeutics Inc. still worth holding after the dip2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
What MACD signals say about Relmada Therapeutics Inc.Analyst Downgrade & Risk Controlled Daily Plans - Newser
Unraveling the Sudden Surge in Relmada Therapeutics (RLMD.O): What's Really Behind the 44.5% Intraday Jump? - AInvest
Relmada Therapeutics (RLMD.O) Surges 44.5% Intraday: Unraveling the Hidden Driver - AInvest
RLMD.O Soars 44.5%—What’s Behind the Surge? - AInvest
3 Promising Penny Stocks With Market Caps Under $400M - Yahoo Finance
Is a relief rally coming for Relmada Therapeutics Inc. holdersFed Meeting & Risk Managed Investment Entry Signals - Newser
Price momentum metrics for Relmada Therapeutics Inc. explainedWeekly Market Outlook & Expert Verified Stock Movement Alerts - Newser
Will Breakout in Relmada Therapeutics Inc. Sustain Through Next Week getLinesFromResByArray error: size == 0 - kangso.co.kr
Best data tools to analyze Relmada Therapeutics Inc. stockInflation Watch & Low Volatility Stock Recommendations - Newser
Relmada Therapeutics Stock (RLMD) Opinions on Clinical Trial Results and Insider Buying - Quiver Quantitative
AI Tools Suggest Relmada Therapeutics Inc. May Outperform This Week2025 Momentum Check & Consistent Profit Trade Alerts - beatles.ru
Is it too late to sell Relmada Therapeutics Inc.Rate Hike & Weekly Watchlist of Top Performers - Newser
Analyzing Relmada Therapeutics Inc. with multi timeframe chartsStop Loss & Fast Momentum Entry Tips - Newser
Historical volatility pattern of Relmada Therapeutics Inc. visualizedPortfolio Performance Report & Pattern Based Trade Signal System - Newser
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):